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Methyl-beta-cyclodextrin Attenuates CaV2.3 Channels Modulation By
NK1 Receptors
Ulises Meza, Yamhilette Lico´n, Sergio Sa´nchez-Armass.
Universidad Auto´noma de San Luis Potosı´, San Luis Potosı´,
SLP, Mexico.
CaV2.3 channels and neurokinin receptors type-1 (NK1R) participate in pain
signaling transmission. Recently, we have shown that CaV2.3 channels, heter-
ologously expressed in HEK293 cells, were inhibited by NK1R through Gq/11
proteins mediated signaling (Meza et al., 2007; Mol Pharmacol 71:284-293).
Here, we report that such inhibitory signaling was attenuated by the treatment
of HEK293 cells with the cholesterol scavenger agent methyl-beta-cyclodex-
trin (MbCD). Our results show that MbCD treatment (15 mM/15 min) signifi-
cantly reduced (47%) inhibition of CaV2.3 channels by NKA (1 microM), a
natural agonist of NK1R. Interestingly, MbCD treatment diminished also the
membrane capacitance (35%), but it did not affect the CaV2.3 current density.
The analysis of macroscopic current biophysical properties (i.e., steady state
voltage dependent activation and inactivation, and activation and inactivation
kinetics) did not show important modifications induced by MbCD treatment.
Our results suggest that MbCD treatment could attenuate the NK1R signaling
pathway by depleting membrane cholesterol and, according with the rafts do-
main hypothesis, by disrupting the signaling complex involved in the inhibitory
modulation of CaV2.3 channels by NK1R.
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Activator of G protein Signaling 1 (AGS1) and Ras homologue enriched in
striatum (Rhes) define a new group of Ras-like monomeric G proteins whose
signaling properties and physiological roles are just beginning to be under-
stood. Previous results suggest that AGS1 and Rhes exhibit distinct preferences
for heterotrimeric G proteins, with AGS1 selectively influencing Gai and Rhes
selectively influencing Gas. Here, we demonstrate that AGS1 and Rhes trigger
nearly identical modulation of N-type Ca2þ channels (CaV2.2) by selectively
altering Gai-dependent signaling. Whole-cell currents were recorded from
HEK293 cells expressing CaV2.2 and Gai- or Gas-coupled receptors. AGS1
and Rhes reduced basal current densities and triggered tonic voltage-dependent
(VD) inhibition of CaV2.2. Furthermore, each protein attenuated agonist-initi-
ated channel inhibition through Gai-coupled receptors without reducing chan-
nel inhibition through a Gas-coupled receptor. The above effects of AGS1 and
Rhes were blocked by pertussis toxin (PTX) or by expression of a Gbg-seques-
tering peptide (masGRK3ct). Transfection with HRas, KRas2, Rap1A-G12V,
Rap2B, Rheb2 or Gem failed to mimic the effects of AGS1 and Rhes on
CaV2.2. Our data provide the first demonstration that AGS1 and Rhes exhibit
similar if not identical signaling properties since both trigger tonic Gbg sig-
naling and both attenuate receptor-initiated signaling by the Gbg subunits of
PTX-sensitive G proteins. These results are consistent with the possibility
that AGS1 and Rhes modulate Ca2þ influx through CaV2.2 channels under
more physiological conditions and thereby influence Ca2þ-dependent events
such as neurosecretion.
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The regulation of Ca2þ influx through the phosphorylation of the L-type Ca2þ
channel, Cav1.2, is important for the modulation of excitation-contraction (E-C)
coupling in the heart. Cav1.2 is thought to be the target of multiple kinases that me-
diate the signals of both the renin-angiotensin and sympathetic nervous systems.
Detailed biochemical information regarding the protein phosphorylation reactions
involved in the regulation of Cav1.2 is limited. The PKC family of kinases can
modulate cardiac contractility in a complex manner, such that contractility is either
enhanced or depressed, and relaxation iseitheraccelerated or slowed. We have pre-
viously reported that Ser1928 in the C-terminus ofa1c was a target for PKCa, z and e
phosphorylation. Using GST fusion proteins of all intracellular domains, we have
mapped additional phosphorylation sites of several PKC isoforms. We then devel-
oped phospho-epitope specific antibodies for these phosphorylation sites to test for
regulation in a heterologous expression system and cardiac myocytes. Here, we re-
port the identification of a new PKC phosphorylation site, Ser1674 in C-terminus ofthe Cav1.2 a1c subunit. Phosphorylation of this site is PKC isoform-specific, as
only PKC a, bI,bII, g, d and q, but not PKC e, z andh, were able to phosphorylate
this site. This site could not be phosphorylated by PKA and PKG in vitro. Using
a phospho-epitope-specific antibodies to Ser1674 (pS1674) and Ser1928 (pS1928),
we demonstrated that both sites within C-terminus are phosphorylated in HEK
cells in response to PMA. Phosphorylation was inhibited with a PKC inhibitor, bi-
sindolylmaleimide. In Langendorff-perfused rat hearts, both Ser1674 and Ser1928
were phosphorylated in response to PMA. In conclusion, we have identified
a new PKC phosphorylation site within the C-terminus of a1c.
Supported by HL68093.
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RGK GTPases potently inhibit CaV channels, an effect with critical (patho)phys-
iological implications and potential biotechnology applications. Mechanisms of
how RGK proteins inhibit ICa are poorly understood. Critical ambiguities sur-
round: (1) whether inhibition occurs exclusively by either reducing the number
of channels (N) at the membrane, or diminishing the activity (Po) of channels in
the membrane, and (2) the role of RGK protein sub-cellular localization. Whole-
cell experiments on recombinant CaV1.2 channels indicated that Rem inhibited
ICa by two distinct effects: a decrease in N, as gauged by gating charge measure-
ments, and a reduction in effective Po of channels at the membrane. These two
effects were kinetically distinguishable. Replacing the membrane-targeting
C-terminus of Rem with the PKCgC1 domain permitted acutely inducible mem-
brane translocation of Rem[265]-C1PKCg and subsequent ICa inhibition by PdBu.
Pdbu activation of Rem[265]-C1PKCg acutely (seconds) inhibited ICa by selec-
tively reducing effective Po, while the decrease in N occurred after a longer
time scale (hours). A prevailing paradigm is that membrane localization is essen-
tial for RGK GTPase inhibition of ICa. Nevertheless, a Rem C-terminus point
mutant, Rem[L271G], that distributes to the nucleus and cytosol, significantly
inhibits ICa leading to a suggestion that nuclear targeting represents an alterna-
tive mechanistic mode of action for Rem. However, Rem[L271G] exclusively
targeted to the nucleus using a nucleus localization sequence had no impact on
ICa. By contrast, an exclusively cytosolic Rem[L271G], achieved using a nucleus
export sequence, essentially ablated ICa, demonstrating a clear-cut exception to
the importance of membrane-targeting for RGK GTPase action on ICa. Our re-
sults reveal that the exceptional potency of Rem in inhibiting ICa is achieved
via an unusual multiplicity of mechanisms and structural determinants.
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L-type voltage dependent calcium channel (L-VDCC) activity is chronically
suppressed in mouse heart overexpressing the ß2-adrenoceptor (Heubach
et al., 2001). We recently demonstrated that this effect is specific for ß2, and
not found with ß1-adrenoceptor overexpression (Foerster et al., 2004). Our
working hypothesis derived from single-channel analysis is that ß2-adrenocep-
tors inhibit L-VDCC activity through activation of Gai3, but not Gai2 protein
(Foerster et al., 2003). Here we examine this idea using cardiac myocytes
from mice with targeted deletion of the pertussis toxin (PTX)-sensitive and
highly homologous Gai isoforms, Gai2 or Gai3.
Both Gai2 and Gai3 are found in cardiac tissue with Gai2 being the predominant
isoform as revealed by immunoblot and ADP-ribosylation studies. Interestingly,
in the absence of Gai2, steady-state protein levels of Gai3 are increased compared
with wild-type levels. In myocytes from Gai2 knockout mice, whole cell L-
VDCC current density was reduced, consistent with findings from previous
single-channel analysis (Foerster et al., 2003). Furthermore, steady state inacti-
vation was shifted to negative voltages and recovery from inactivation was re-
tarded, arguing in favor for modulatory effects rather than a simple adaptation
of the channel number. In contrast, myocytes from Gai3 knockout mice revealed
no alteration of kinetic parameters. Cholinergic inhibition of L-VDCC current
after isoprenalin stimulation was intact. However, basal current density was
increased in Gai3 knockout myocytes. All genotype-related differences were
ablated following incubation with PTX for 3 hrs. In conclusion, isoform-specific
differential modulation of L-VDCC by Gai2 and Gai3 was confirmed at the
whole-cell current level using mouse knockout models for both proteins. The
role of Gai-isoforms in pathological adrenergic overstimulation should be
further explored.
